News from watson pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 24, 2013, 09:00 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Watson Pharmaceuticals, Inc. is Now Actavis, Inc.

 Watson Pharmaceuticals, Inc. today announced that the company has adopted Actavis, Inc. (NYSE: ACT) as its new global name and will today...

Jan 23, 2013, 09:29 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson Confirms Opana® ER Patent Challenge

  Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that Actavis South Atlantic LLC, which was acquired by Watson in...

Jan 23, 2013, 07:30 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson Acquires Uteron Pharma SA

 Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has completed the acquisition of Belgium-based Uteron Pharma SA for $150...

Jan 11, 2013, 09:15 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson To Host 2013 Investor Meeting January 25 In New York

 Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that it will host an Investor...

Jan 03, 2013, 09:00 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson's Generic Lysteda® Receives FDA Approval

 Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary Watson Laboratories, Inc. – Florida has received approval...

Dec 28, 2012, 09:00 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson Confirms Velcade® Patent Challenge

 Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that Actavis, Inc., which was acquired by Watson in October, has filed an...

Dec 21, 2012, 09:15 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson to Present at the 31st Annual J.P. Morgan Healthcare Conference

 Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's President...

Dec 20, 2012, 09:15 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson to Present at 2013 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top

Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's President and...

Nov 14, 2012, 09:15 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson to Present at the 2012 Piper Jaffray Health Care Conference

 Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's President...

Nov 12, 2012, 08:41 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson's Generic Revatio® Receives FDA Approval

Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary Watson Laboratories, Inc. has received approval from the U.S. Food...

Nov 06, 2012, 16:15 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson to Present at the Jefferies 2012 Global Healthcare Conference

Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that Siggi Olafsson, Watson's President,...

Nov 06, 2012, 09:00 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson to Present at the 2012 Annual Credit Suisse Healthcare Conference

 Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's President and...

Nov 01, 2012, 06:30 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson Third Quarter 2012 Non-GAAP Diluted EPS Increases 24% to $1.35; Net Revenue Increases 19% to $1.29 Billion

Watson Pharmaceuticals, Inc. (NYSE: WPI) today reported net income for the third quarter 2012 increased 24.2 percent to $172.3 million or $1.35 per...

Oct 31, 2012, 19:40 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson Announces Global Generics Management Team

Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced the Global Generics management team, following the announcement of the completion of the...

Oct 31, 2012, 19:35 ET
New Actavis Logo.  (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson Announces New Name -- Actavis -- for Global Operations

Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it will adopt a new global name – Actavis – effective in 2013. The...

Oct 31, 2012, 19:30 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson Completes Actavis Acquisition

Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has completed the acquisition of the Actavis Group for EUR 4.25 billion....

Oct 29, 2012, 10:02 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson Announces Sale of Rugby OTC Product Trademark and Assets to Major Pharmaceuticals, a division of The Harvard Drug Group, LLC

 Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that it has sold its Rugby...

Oct 26, 2012, 16:22 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson Receives FDA Approval for Generic Actos®

 Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that Watson has launched a generic version of Actos® (Pioglitazone...

Oct 26, 2012, 08:30 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson Confirms FDA Denies Appeal Related to Prochieve® NDA for the Prevention of Preterm Birth

 Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that the U.S. Food and Drug Administration (FDA) denied the Company's Formal Dispute...

Oct 22, 2012, 18:08 ET
Watson Pharmaceuticals, Inc. LOGO. (PRNewsFoto/Watson Pharmaceuticals, Inc.)

Watson Receives Favorable Court Decision Regarding Generic Actos® Approval

 Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that U.S. District Court for the District of Columbia has granted summary judgment...